Literature DB >> 11709097

Characterization of full-length HIV type 1 subtype C sequences from South Africa.

J van Harmelen1, C Williamson, B Kim, L Morris, J Carr, S S Karim, F McCutchan.   

Abstract

Four full-length genome subtype C sequences from South Africa, three of which are being used for vaccine development, were characterized. Three isolates were obtained from recently infected individuals in KwaZulu/Natal: Du151, Du422, and Du179. A fourth isolate, CTSc2, was obtained from an individual residing in Cape Town. All four strains used the CCR5 coreceptor, although Du179 also used CXCR4. The four isolates clustered within subtype C, but the three Du isolates formed a subcluster with a bootstrap value of 100%, with CTSc2 outside the subcluster. None of the strains showed evidence of intersubtype recombination, as expected from the predominance of subtype C in South Africa. All 4 isolates had a 16-amino acid truncation on the 3' end of the Rev protein, identified in other subtype C isolates. Like many other subtype C strains, Du151, Du422, and Du179 had three NF-kappa B-binding sites in the LTR; however, CTSc2 had only two.

Entities:  

Mesh:

Year:  2001        PMID: 11709097     DOI: 10.1089/08892220152644232

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  20 in total

1.  Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates.

Authors:  Gillian M Hunt; Maria A Papathanasopoulos; Glenda E Gray; Caroline T Tiemessen
Journal:  Virus Genes       Date:  2003-01       Impact factor: 2.332

2.  Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies.

Authors:  M Gordon; T De Oliveira; K Bishop; H M Coovadia; L Madurai; S Engelbrecht; E Janse van Rensburg; A Mosam; A Smith; S Cassol
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

3.  The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells.

Authors:  Kabamba B Alexandre; Elin S Gray; Hazel Mufhandu; James B McMahon; Ereck Chakauya; Barry R O'Keefe; Rachel Chikwamba; Lynn Morris
Journal:  Virology       Date:  2011-12-29       Impact factor: 3.616

4.  Major histocompatibility complex class II (HLA-DRB and -DQB) allele frequencies in Botswana: association with human immunodeficiency virus type 1 infection.

Authors:  Thumbi Ndung'u; Simani Gaseitsiwe; Enoch Sepako; Florence Doualla-Bell; Trevor Peter; Soyeon Kim; Ibou Thior; Vladimir A Novitsky; Max Essex
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

5.  Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin.

Authors:  Kabamba B Alexandre; Elin S Gray; Bronwen E Lambson; Penny L Moore; Isaac A Choge; Koleka Mlisana; Salim S Abdool Karim; James McMahon; Barry O'Keefe; Rachel Chikwamba; Lynn Morris
Journal:  Virology       Date:  2010-04-13       Impact factor: 3.616

6.  Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine.

Authors:  Jian Yan; Natasha Corbitt; Panyupa Pankhong; Thomas Shin; Amir Khan; Niranjan Y Sardesai; David B Weiner
Journal:  Vaccine       Date:  2011-06-07       Impact factor: 3.641

7.  Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?

Authors:  V Novitsky; U R Smith; P Gilbert; M F McLane; P Chigwedere; C Williamson; T Ndung'u; I Klein; S Y Chang; T Peter; I Thior; B T Foley; S Gaolekwe; N Rybak; S Gaseitsiwe; F Vannberg; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

8.  Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.

Authors:  V Novitsky; H Cao; N Rybak; P Gilbert; M F McLane; S Gaolekwe; T Peter; I Thior; T Ndung'u; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 9.  HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response.

Authors:  Salim S Abdool Karim; Gavin J Churchyard; Quarraisha Abdool Karim; Stephen D Lawn
Journal:  Lancet       Date:  2009-08-24       Impact factor: 79.321

10.  Evolution of proviral gp120 over the first year of HIV-1 subtype C infection.

Authors:  Vladimir Novitsky; Stephen Lagakos; Michaela Herzig; Caitlin Bonney; Lemme Kebaabetswe; Raabya Rossenkhan; David Nkwe; Lauren Margolin; Rosemary Musonda; Sikhulile Moyo; Elias Woldegabriel; Erik van Widenfelt; Joseph Makhema; M Essex
Journal:  Virology       Date:  2008-10-29       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.